Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-24-019343

VP, Clinical Trial Operations sold 6,849 shares at $2.12 ($14,520)

  • VP, Clinical Trial Operations acquired 15,218 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Yu Yong VP, Clinical Trial Operations 2024-02-19 Grant or award +3,661 6,161 D
Yu Yong VP, Clinical Trial Operations 2024-03-14 Grant or award +11,557 17,718 D
Yu Yong VP, Clinical Trial Operations 2024-06-24 Sale −6,849 $2.12 $14,520 10,869 D
Open-market sales · 6,849 sh · avg $2.12 · $14,520
Loading xslF345X05/form4-07082024_040709.xml…